yingweiwo

Dihydro-5-azacytidine (DHAC; NSC 264880)

Dihydro-5-azacytidine (DHAC) is a nucleoside analog that can be incorporated into DNA and inhibit DNA methylation.
Dihydro-5-azacytidine (DHAC; NSC 264880)
Dihydro-5-azacytidine (DHAC; NSC 264880) Chemical Structure CAS No.: 62488-57-7
Product category: DNA Methyltransferase
This product is for research use only, not for human use. We do not sell to patients.
Size Price
5mg
100mg
Other Sizes

Other Forms of Dihydro-5-azacytidine (DHAC; NSC 264880):

  • Dihydro-5-azacytidine acetate (DHAC acetate; NSC 264880 acetate)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
Dihydro-5-azacytidine (DHAC) is a nucleoside analog that can be incorporated into DNA and inhibit DNA methylation. Dihydro-5-azacytidine has anti-tumor effects.
Dihydro-5-azacytidine (DHAC; NSC 264880) (CAS#: 62488-57-7) is a synthetic nucleoside analog of deoxycytidine, with the molecular formula C8H14N4O5 and a molecular weight of 246.22 g/mol. It is a DNA methyltransferase inhibitor, which means it interferes with the epigenetic regulation of gene expression by inhibiting the methylation of DNA. This mechanism is similar to that of the approved drug 5-azacytidine, but DHAC is a dihydro derivative. By inhibiting DNA methylation, DHAC can reactivate silenced genes, including tumor suppressor genes, and thereby exert antitumor activity. It has been investigated in clinical trials for the treatment of various cancers, including leukemia and solid tumors.
Biological Activity I Assay Protocols (From Reference)
Targets
The primary biological target of DHAC is DNA methyltransferase (DNMT), specifically DNMT1. By incorporating into DNA, DHAC forms a covalent bond with the enzyme, leading to its inactivation. This results in the hypomethylation of DNA and the reactivation of genes that have been silenced by aberrant methylation, a common event in tumorigenesis. This mechanism of action makes it a valuable tool for epigenetic therapy. The compound's ability to interfere with abnormal DNA methylation patterns associated with genetic instability in some tumor cells is the basis for its anticancer activity.
ln Vitro
Methylation experiments reveal that, in comparison to their respective controls, an LD10 dose of [3H]DHAC causes a 25.06% hypomethylation of DNA in L1210/0 cells and a 46.32% hypomethylation in a deoxycytidine kinase mutant cell line L1210/dCK(-)[2]. When cytidine triphosphate and dihydro-5-azacytidine (DHAC) compete to be incorporated into RNA, ribosome breakdown and aberrant protein synthesis result[1].
In vitro, DHAC has been shown to inhibit DNA methylation and to induce the differentiation of certain leukemia cell lines. It exhibits antiproliferative activity against various cancer cell lines, although its potency is generally lower than that of 5-azacytidine. The specific IC50 values vary depending on the cell line and the duration of exposure. It has also been shown to induce apoptosis in some cancer cells. The compound's effects on gene expression are often studied by measuring the reactivation of methylation-silenced genes, such as tumor suppressor genes, using quantitative RT-PCR.
ln Vivo
Following an LD10 dose of Dihydro-5-azacytidine (DHAC; 1500 mg/kg) in tumor-bearing mice (injected with L1210/0 cells), the plasma peak concentration reached is 317 μM, and it is removed biexponentially, with a t1/ 2 α of 1.03 h and a t1/2 β of 5 h[2].
In vivo, DHAC has been evaluated in animal models of cancer, where it has demonstrated antitumor activity. It has also been tested in clinical trials, but its development was limited by its poor oral bioavailability and its rapid deamination by cytidine deaminase. To overcome these limitations, various prodrug strategies and delivery methods have been explored. The compound's pharmacokinetic properties, including its short half-life and rapid clearance, have been a challenge for its clinical development. Despite this, it remains a useful research tool for studying the effects of DNA methylation inhibition.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for DHAC involves measuring its ability to inhibit DNA methyltransferase activity. This is typically done using a biochemical assay with purified DNMT1 enzyme and a radiolabeled or fluorescently labeled DNA substrate. The assay measures the transfer of a methyl group from S-adenosylmethionine (SAM) to the DNA. The compound's inhibitory effect is quantified by measuring the reduction in methyl group incorporation. This type of assay is essential for confirming the compound's direct interaction with its target enzyme and for studying its mechanism of action.
Cell Assay
The in vitro cellular assay for DHAC involves treating cancer cell lines with various concentrations of the compound. The effect on DNA methylation is assessed by measuring the global level of 5-methylcytosine in DNA using a dot blot assay or by using bisulfite sequencing to analyze the methylation status of specific gene promoters. The reactivation of silenced genes is measured by quantitative RT-PCR. Antiproliferative activity is assessed using standard cell viability assays such as MTT. Apoptosis is evaluated using flow cytometry with Annexin V/PI staining. These assays are used to study the epigenetic and anticancer effects of DHAC.
Animal Protocol
The in vivo animal experiment workflow for DHAC has been established in several studies. A common approach involves the use of a xenograft model in immunodeficient mice. Cancer cells are injected subcutaneously, and once tumors form, DHAC is administered at various doses and routes (e.g., intraperitoneal, intravenous). Tumor growth is monitored by measuring tumor volume. The effect on DNA methylation in the tumor tissue is assessed by measuring global 5-methylcytosine levels or by analyzing the methylation status of specific genes. These studies have provided valuable data on the pharmacokinetics and pharmacodynamics of DHAC.
Toxicity/Toxicokinetics
Toxicity Data
Mice (intravenous injection): LD50: 2559 mg/kg
References

[1]. Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904. J Thorac Oncol. 2008 Apr;3(4):417-21.

[2]. Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice. Cancer Chemother Pharmacol. 1988;21(2):117-21.

Additional Infomation
5,6-Dihydro-5-azacytidine is a white powder. (NTP, 1992)
Dihydro-5-azacytidine is a synthetic nucleoside analog of deoxycytidine. Dihydro-5-azacytidine inhibits DNA methyltransferases, thereby interfering with abnormal DNA methylation patterns associated with genetic instability in certain tumor cells. Inhibition of this enzyme may restore the expression of tumor suppressor genes and produce antitumor activity. (NCI04)
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C8H14N4O5
Molecular Weight
246.22
Exact Mass
246.096
CAS #
62488-57-7
Related CAS #
Dihydro-5-azacytidine acetate;2470972-18-8
PubChem CID
99681
Appearance
Typically exists as solid at room temperature
Density
2.1±0.1 g/cm3
Boiling Point
529.1ºC at 760 mmHg
Melting Point
360 to 365 °F (NTP, 1992)
Flash Point
273.8ºC
Index of Refraction
1.823
LogP
-2.2
tPSA
140.64
Hydrogen Bond Donor Count
5
Hydrogen Bond Acceptor Count
6
Rotatable Bond Count
2
Heavy Atom Count
17
Complexity
349
Defined Atom Stereocenter Count
4
SMILES
OCC1OC(N2CN=C(N)NC2=O)C(O)C1O
InChi Key
LJIRBXZDQGQUOO-KVTDHHQDSA-N
InChi Code
InChI=1S/C8H14N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h3-6,13-15H,1-2H2,(H3,9,10,11,16)/t3-,4-,5-,6-/m1/s1
Chemical Name
6-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,4-dihydro-1,3,5-triazin-2-one
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.0614 mL 20.3070 mL 40.6141 mL
5 mM 0.8123 mL 4.0614 mL 8.1228 mL
10 mM 0.4061 mL 2.0307 mL 4.0614 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us